In fact, in recent years, epidemic prevention and control bonds have come out. In February 5th, the novel coronavirus pneumonia Limited by Share Ltd issued the first phase of Shanghai Sichuan 2020 super short-term financing coupons, which was used to supplement the Coren pharmaceutical research and development, procurement, production and fight against the new crown pneumonia epidemic medical supplies. On February 10, the fourth super short-term financing bond of Shenzhen Airlines Co., Ltd. in 2020, which is mainly underwritten by Bank of Shanghai, completed bookkeeping, and the part of raised funds was used to supplement the operating funds of Shenzhen Airlines for free transportation of rescue materials and medical personnel to help fight against the epidemic, and for free handling of refunds, ticket changes and other expenditures for passengers. Last week, the National Development Bank, the Agricultural Development Bank of China, the Export Import Bank of China and a number of enterprises also issued anti epidemic special bonds.
The reporter learned in the interview that institutional investors are enthusiastic about the subscription of the above-mentioned special bonds against epidemic, and there may be more large-scale issuance of epidemic prevention and control bonds in the follow-up, and many large-scale public funds begin to plan to prepare relevant products.
Extended reading of the rising trend of science and technology innovation board, gratifying science and technology shares are sought after by institutions, and the public funds record the bottom reading of a large amount of funds, and apply for the bottom reading of ETFs for one week, 16 billion 90% of the funds recover the golden pit which has earned 40% of the maximum since this year. Source: responsible editor of Shanghai Securities News: Ren Hui ufe50 nbj9607